Four recent clinical studies have demonstrated that silver in a variety of forms — including colloidal silver — is able to cure the deadly antibiotic-resistant MRSA infections that now kill more Americans each year than AIDS infections.
Here is a brief synopsis of the recently revealed good news regarding the incredible infection-fighting qualities of colloidal silver, proving beyond any shadow of a doubt its ability to kill MRSA and other deadly antibiotic-resistant pathogens – often in just minutes!
Case #1: A Brigham Young Clinical Study Proves Silver Kills MRSA — In this study, conducted quietly in October 2006 at the Department of Microbiology/Molecular Biology of Brigham Young University, and published in the journal Current Science, Vol. 91, No. 7, October 10, 2006, it was found that a number of the antibiotic drugs which formerly killed MDR (multiple drug-resistant) pathogens such as MRSA could actually be restored to full efficacy against the deadly pathogens, but only if a liquid silver solution similar to colloidal silver was used in conjunction with the drug! The researchers wrote:
“Silver-Water-Dispersion(TM) solution has been shown as an effective antibiotic against many Methicillin-resistant Staphylococcus aureus (MRSA) and multiple drug-resistant (MDR) strains (Escherichia coli, Pseudomonas aeruginosa). As high level acquired resistance to conventional antibiotics is frequent, it seems reasonable to use combination therapy in order to achieve bactericidal synergism. Active silver solutions have shown marked activity against proven bacterial-resistant strains. Hence, a range of antibiotics were tested with Silver-Water Dispersion(TM) solution to determine antagonism, additive and synergistic effects against a panel of microbial strains… It is clear that the combination will allow a more complete clearing of the pathological organism.”
In short, what the researchers found is that when they used the liquid silver solution in conjunction with the antibiotic drugs that had previously lost their effectiveness against MRSA and other deadly super pathogens, the antibiotics began to work again. The synergism between silver and the antibiotic drugs brought the deadly pathogens back under control. Since the antibiotic drugs had previously lost their effectiveness against the super pathogens, this clearly demonstrates that the silver was the deciding factor in the deaths of the deadly pathogens!
Case #2: Iranian Clinical Study Proves Silver Increases Effectiveness of Antibiotic Drugs Against Staph – This study was conducted by the Department of Pharmaceutical Biotechnology and Medical Nanotechnology Research Center, Faculty of Pharmacy and Medical Sciences at the University of Tehran, Iran. Say what you will about the Iranians, but when they do a medical study, they do it up right. Apparently Iranian scientists were two full months ahead of the Brigham Young team above in proving that the addition of silver to antibiotic drugs boosts their ability to kill resistant staphylococcus aureaus. The study was called, “Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli.” In part, the researchers demonstrated:
“Silver nanoparticles (Ag-NPs) have been known to have inhibitory and bactericidal effects. Resistance to antimicrobial agents by pathogenic bacteria has emerged in recent years and is a major health problem. …these [silver] nanoparticles were evaluated for their part in increasing the antimicrobial activities of various antibiotics against Staphylococcus aureus and Escherichia coli. The antibacterial activities of penicillin G, amoxicillin, erythromycin, clindamycin, and vancomycin were increased in the presence of silver nano-particles (Ag-NPs) against both test strains. The highest enhancing effects were observed for vancomycin, amoxicillin, and penicillin G against S. aureus.
So once again we see that it is the addition of silver to the three specific antibiotics (vancomycin, amoxicillin and penicillin) that almost magically renews the effectiveness of each of these antibiotic drugs against today’s most deadly pathogens. Silver, as usual, is the key!
Case #3: Taiwanese Clinical Study Proves Colloidal Silver By Itself Kills MRSA — Another study, this one conducted in Taiwan, also demonstrated that silver colloids kills both MRSA and Pseudomonas aeruginosa, another deadly and extremely opportunistic superbug. In this study, a special colloidal silver solution was tested on contact surfaces where the deadly pathogens are known to colonize, and from which they can spread to humans. The silver solution proved to be completely effective against both the MRSA and Pseudomonas super pathogens.
The study, which demonstrated conclusively that silver could be applied to contact surfaces to stop colonies of MRSA super pathogens from forming, was titled, “Formation of colloidal silver nanoparticles stabilized by Na(+)-poly(gamma-glutamic acid)-silver nitrate complex via chemical reduction process,” and was conducted at the Department of Textile Science, Nanya Institute of Technology, Chung-Li, Tao-Yuan, Taiwan. It was published in the journal Colloids Surface B Biointerfaces in October 2007.
Case #4: Czech Clinical Study Proves Silver Particles Kill MRSA – This study was conducted at the Department of Physical Chemistry at Palacky University in the Czech Republic. It was later published in the prestigious Journal of Physical Chemistry B in August 2006. Titled “Silver colloidal nanoparticles: synthesis, characterization, and their antibacterial activity,” the study demonstrated that…
“…silver particles with a narrow size distribution with an average size of 25 nm, which showed high antimicrobial and bactericidal activity against Gram-positive and Gram-negative bacteria, including highly multi-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA).” The study further demonstrated that very low concentrations of silver could be utilized to destroy MRSA, as long as the silver particles were very small, averaging 25 nm.